Companies to Watch: Sensorion

Sensorion is a public company in France developing new medicines for diseases of the inner ear, with two compounds in the pipeline: SENS- 111 for treating acute unilateral vestibulopathy…

By Michael Tattory| 2018-06-07T13:55:47-04:00 June 1st, 2018|News|Comments Off

About the Author: Michael Tattory

Surprise man battling rare disease helping researchers come up with treatment
Gallery
Surprise man battling rare disease helping researchers come up with treatment
Driving Drug Discovery Using Patients’ Immune Response
Gallery
Driving Drug Discovery Using Patients’ Immune Response
IPO Window, Recession, Trade War & More — 5 Biopharma Finance Experts Share Their Perspectives For 2020
Gallery
IPO Window, Recession, Trade War & More — 5 Biopharma Finance Experts Share Their Perspectives For 2020
Pfizer, Novartis lead $2 billion spending spree on gene therapy production
Gallery
Pfizer, Novartis lead $2 billion spending spree on gene therapy production
ProQR: Developing RNA Therapies for Rare Genetic Disorders
Gallery
ProQR: Developing RNA Therapies for Rare Genetic Disorders

Companies to Watch: Sensorion

Companies to Watch: Sensorion

Share This Story, Choose Your Platform!

About the Author: Michael Tattory

Related Posts

Surprise man battling rare disease helping researchers come up with treatment

Driving Drug Discovery Using Patients’ Immune Response

IPO Window, Recession, Trade War & More — 5 Biopharma Finance Experts Share Their Perspectives For 2020

Pfizer, Novartis lead $2 billion spending spree on gene therapy production

ProQR: Developing RNA Therapies for Rare Genetic Disorders